Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

References for PMC Articles for PubMed (Select 20308661)

1.

Cancer statistics, 2009.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

2.

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.

Ellis P, Barrett-Lee P, Johnson L, Cameron D, Wardley A, O'Reilly S, Verrill M, Smith I, Yarnold J, Coleman R, Earl H, Canney P, Twelves C, Poole C, Bloomfield D, Hopwood P, Johnston S, Dowsett M, Bartlett JM, Ellis I, Peckitt C, Hall E, Bliss JM; TACT Trial Management Group; TACT Trialists.

Lancet. 2009 May 16;373(9676):1681-92. doi: 10.1016/S0140-6736(09)60740-6.

3.

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.

Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, De Lafontan B, Zoubir M, Maingon P, Mignotte H, de Lara CT, Edeline J, Penault-Llorca F, Romestaing P, Delva C, Comet B, Belkacemi Y.

Crit Rev Oncol Hematol. 2010 Mar;73(3):246-54. doi: 10.1016/j.critrevonc.2009.04.002. Epub 2009 May 12.

PMID:
19442535
4.

Multiple primary tumors in men with breast cancer diagnoses: a SEER database review.

Wernberg JA, Yap J, Murekeyisoni C, Mashtare T, Wilding GE, Kulkarni SA.

J Surg Oncol. 2009 Jan 1;99(1):16-9. doi: 10.1002/jso.21153.

PMID:
18937232
5.

Prospective evaluation of risk factors for male breast cancer.

Brinton LA, Richesson DA, Gierach GL, Lacey JV Jr, Park Y, Hollenbeck AR, Schatzkin A.

J Natl Cancer Inst. 2008 Oct 15;100(20):1477-81. doi: 10.1093/jnci/djn329. Epub 2008 Oct 7.

6.

Sentinel lymph node biopsy is successful and accurate in male breast carcinoma.

Flynn LW, Park J, Patil SM, Cody HS 3rd, Port ER.

J Am Coll Surg. 2008 Apr;206(4):616-21. doi: 10.1016/j.jamcollsurg.2007.11.005. Epub 2008 Feb 21.

PMID:
18387465
7.

How to treat male breast cancer.

Czene K, Bergqvist J, Hall P, Bergh J.

Breast. 2007 Dec;16 Suppl 2:S147-54. Review. Erratum in: Breast. 2008 Jun;17(3):319. Kamila, Czene [corrected to Czene, Kamila]; Jenny, Bergqvist [corrected to Bergqvist, Jenny]; Per, Hall [corrected to Hall, Per]; Jonas, Bergh [corrected to Bergh, Jonas].

PMID:
18210656
8.

Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.

Chodick G, Struewing JP, Ron E, Rutter JL, Iscovich J.

Eur J Med Genet. 2008 Mar-Apr;51(2):141-7. Epub 2007 Nov 22.

9.

Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

Tai YC, Domchek S, Parmigiani G, Chen S.

J Natl Cancer Inst. 2007 Dec 5;99(23):1811-4. Epub 2007 Nov 27.

10.

Sentinel lymph node biopsy in male patients with early breast cancer.

Gentilini O, Chagas E, Zurrida S, Intra M, De Cicco C, Gatti G, Silva L, Renne G, Cassano E, Veronesi U.

Oncologist. 2007 May;12(5):512-5.

11.

Racial disparities in treatment and survival of male breast cancer.

Crew KD, Neugut AI, Wang X, Jacobson JS, Grann VR, Raptis G, Hershman DL.

J Clin Oncol. 2007 Mar 20;25(9):1089-98.

12.

Male breast cancer in the veterans affairs population: a comparative analysis.

Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R.

Cancer. 2007 Apr 15;109(8):1471-7.

13.

Strategies in treating male breast cancer.

Cutuli B.

Expert Opin Pharmacother. 2007 Feb;8(2):193-202. Review.

PMID:
17257089
14.

A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up.

Walshe JM, Berman AW, Vatas U, Steinberg SM, Anderson WF, Lippman ME, Swain SM.

Breast Cancer Res Treat. 2007 Jun;103(2):177-83. Epub 2006 Oct 13.

PMID:
17039267
15.

Cytokeratin profiles of male breast cancers.

Ciocca V, Bombonati A, Gatalica Z, Di Pasquale M, Milos A, Ruiz-Orrico A, Dreher D, Folch N, Monzon F, Santeusanio G, Perou CM, Bernard PS, Palazzo JP.

Histopathology. 2006 Oct;49(4):365-70.

PMID:
16978199
16.

Leuprolide acetate plus aromatase inhibition for male breast cancer.

Giordano SH, Hortobagyi GN.

J Clin Oncol. 2006 Jul 20;24(21):e42-3. No abstract available.

17.

Male breast cancer.

Fentiman IS, Fourquet A, Hortobagyi GN.

Lancet. 2006 Feb 18;367(9510):595-604. Review. Erratum in: Lancet. 2006 Jun 3;367(9525):1818.

PMID:
16488803
18.

Adjuvant systemic therapy for male breast carcinoma.

Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN.

Cancer. 2005 Dec 1;104(11):2359-64.

19.

Male breast cancer incidence among atomic bomb survivors.

Ron E, Ikeda T, Preston DL, Tokuoka S.

J Natl Cancer Inst. 2005 Apr 20;97(8):603-5.

20.

Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.

Anderson WF, Chu KC, Chang S, Sherman ME.

Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1128-35.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk